Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 15/20 | 0.68 |
| ▸ | ITGA4 | P13612 | 15/20 | 0.68 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.48 |
| ▸ | ITGAV | P06756 | 2/20 | 0.48 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.44 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5700988 | 1.00 | ITGB1 (0.68) | ITGB1ITGA4ITGB3ITGAVITGB7 | |
| SCHEMBL5700888 | 0.94 | ITGB1 (0.61) | ITGB1ITGA4ITGB3ITGAVPI4KB | |
| SCHEMBL5700883 | 0.94 | ITGB1 (0.61) | ITGB1ITGA4ITGB3ITGAVPI4KB | |
| SCHEMBL5705101 | 0.93 | ITGB1 (0.76) | ITGB1ITGA4ITGB3ITGAVITGB7 | |
| SCHEMBL5705104 | 0.93 | ITGB1 (0.76) | ITGB1ITGA4ITGB3ITGAVITGB7 | |
| SCHEMBL7391722 | 0.91 | ITGB1 (0.57) | ITGB1ITGA4ITGB3ITGAVPI4KB | |
| SCHEMBL7422070 | 0.91 | ITGB1 (0.59) | ITGB1ITGA4ITGB3ITGAVPI4KB | |
| SCHEMBL5700952 | 0.88 | ITGB1 (0.70) | ITGB1ITGA4ITGB7MEN1KMT2A | |
| SCHEMBL5700947 | 0.88 | ITGB1 (0.70) | ITGB1ITGA4ITGB7MEN1KMT2A | |
| SCHEMBL7387410 | 0.87 | ITGB1 (0.69) | ITGB1ITGA4ITGB7MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1027328-B1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LTD (GB) | 2006-08-23 | — | — | EP | disclosed |